Clinical trials
Alzheimer Disease trials in New Zealand
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 4 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 9 |
| Recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 5 |
| AbbVie | 3 |
| GlaxoSmithKline | 3 |
| Washington University School of Medicine | 2 |
| Alector Inc. | 1 |
| Arrowhead Pharmaceuticals | 1 |
| Biomed Industries, Inc. | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| Eli Lilly and Company | 1 |
| Forest Laboratories | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 22 |
| Dementia | 6 |
| Neurodegenerative Diseases | 4 |
| Cognitive Dysfunction | 3 |
| Memory Disorders | 2 |
| Tauopathies | 2 |
| Amyloid Neuropathies, Familial | 1 |
| Amyloidosis | 1 |
| Cardiomyopathies | 1 |
| Dementia, Vascular | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.